Related Experiment Video
Updated: Jun 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
SERUM TREATMENT OF INFLUENZAL MENINGITIS
1Laboratories of the Rockefeller Institute for Medical Research, New York.
Abstract:
The injection of virulent cultures of Bacillus influenzae into the subdural space of several species of lower monkeys is followed by the development of an acute inflammation of the meninges, corresponding in clinical, bacteriological, and pathological effects with influenzal cerebrospinal meningitis in human beings. Experimental influenzal meningitis in the monkey is a lethal disease which terminates fatally in from thirty-six hours to four days after the inoculation. The injected influenza bacilli produce their effects through multiplication in the course of which they penetrate from the subdural space into the general blood current, from which they may be recovered during life and at autopsy, as is also true of the spontaneous form of influenzal meningitis in man. By repeated injection, over a period of many months, of living virulent cultures of Bacillus influenzae into the goat, an immune serum possessing moderate agglutinating and high opsonic power may be produced, which is capable, when injected into the subdural space, of arresting the progress of an experimental influenzal meningitis, and of bringing about recovery in monkeys thus affected. As a result of the serum injections, the influenza bacilli in the meninges are more freely englobed by phagocytes, their number is reduced, their capacity of growth diminished, and the eruption into the blood arrested. Along with these effects go, hand in hand, cessation of the local inflammatory process and progressive amelioration of the symptoms of illness, to be followed usually by rapid restoration of health. In view of the highly fatal character of influenzal meningitis in human beings, the employment of an immune serum by subdural injection is recommended. Undoubtedly it will be necessary to apply the serum early and by repeated injections, by means of lumbar puncture, to secure beneficial results. The early application will, in turn, be dependent upon prompt bacteriological diagnosis, which can be made, as a rule, by the immediate microscopical examination of the cerebrospinal fluid without the employment of cultural methods. When possible, the microscopical diagnosis should be confirmed by cultural tests.
Insights
Developing an immune serum against Bacillus influenzae offers a promising treatment for influenzal meningitis. Subdural injection of this serum in monkeys successfully treated experimental meningitis, suggesting potential for human application.
Area of Science:
- Medical Microbiology
- Immunology
- Neurology
Background:
- Influenzal cerebrospinal meningitis is a severe, often fatal, condition in humans.
- Experimental models are crucial for understanding disease pathogenesis and testing therapies.
Purpose of the Study:
- To investigate the efficacy of an immune serum in treating experimental influenzal meningitis.
- To evaluate the therapeutic potential of subdural serum injection for this condition.
Main Methods:
- Induction of acute influenzal meningitis in monkeys via subdural injection of virulent Bacillus influenzae.
- Production of an immune serum in goats through repeated injections of Bacillus influenzae.
- Administration of the immune serum via subdural injection into affected monkeys.
Main Results:
- Experimental meningitis in monkeys was lethal within 36 hours to 4 days.
- Immune serum demonstrated moderate agglutinating and high opsonic power.
- Subdural serum injection arrested meningitis progression and led to recovery in monkeys, with reduced bacterial load and inflammation.
Conclusions:
- An immune serum produced in goats can effectively treat experimental influenzal meningitis in monkeys.
- Subdural administration of this immune serum is a recommended therapeutic strategy.
- Early diagnosis via cerebrospinal fluid microscopy and prompt, repeated serum injections are vital for successful treatment.
Related Concept Videos
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Respiratory Syncytial Virus Disease

